MarketsSingle-source
2.1
Double Bond Pharma reports Q2 2026 operating loss of 0.6 million SEK
Dagens IndustriLO·SE·about 13 hours ago
Medical technology firm Polarcool reported net sales of 0.8 million SEK for Q2 2026, up slightly from 0.7 million SEK in the prior year period. The company's operating loss widened, reflecting ongoing expenditure pressures typical of its current growth phase.